ECSP22049014A - Variantes de progranulina - Google Patents
Variantes de progranulinaInfo
- Publication number
- ECSP22049014A ECSP22049014A ECSENADI202249014A ECDI202249014A ECSP22049014A EC SP22049014 A ECSP22049014 A EC SP22049014A EC SENADI202249014 A ECSENADI202249014 A EC SENADI202249014A EC DI202249014 A ECDI202249014 A EC DI202249014A EC SP22049014 A ECSP22049014 A EC SP22049014A
- Authority
- EC
- Ecuador
- Prior art keywords
- progranulin
- variants
- proteins
- ftd
- polypeptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Abstract
Se proporcionan en la presente variantes de progranulina y prote?nas de fusi?n que comprenden una variante de progranulina y un polip?ptido Fc. Tambi?n se proporcionan en la presente m?todos para el uso de dichas prote?nas para el tratamiento de trastornos asociados con la progranulina (por ejemplo, una enfermedad neurodegenerativa, tal como demencia frontotemporal (FTD)).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962953099P | 2019-12-23 | 2019-12-23 | |
US202063091819P | 2020-10-14 | 2020-10-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP22049014A true ECSP22049014A (es) | 2022-07-29 |
Family
ID=74184961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSENADI202249014A ECSP22049014A (es) | 2019-12-23 | 2022-06-21 | Variantes de progranulina |
Country Status (4)
Country | Link |
---|---|
CL (1) | CL2022001712A1 (es) |
EC (1) | ECSP22049014A (es) |
TW (1) | TW202138384A (es) |
WO (1) | WO2021133907A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20231931A1 (es) | 2020-10-14 | 2023-12-01 | Denali Therapeutics Inc | Proteinas de fusion que comprenden enzimas sulfoglucosamina sulfohidrolasa y metodos de estas |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018013775A2 (en) * | 2016-07-14 | 2018-01-18 | Emory University | Granulin compositions and uses related thereto |
SG11201907419PA (en) | 2017-02-17 | 2019-09-27 | Denali Therapeutics Inc | Transferrin receptor transgenic models |
AU2018221731C1 (en) | 2017-02-17 | 2021-11-18 | Denali Therapeutics Inc. | Engineered transferrin receptor binding polypeptides |
-
2020
- 2020-12-23 TW TW109145722A patent/TW202138384A/zh unknown
- 2020-12-23 WO PCT/US2020/066831 patent/WO2021133907A1/en unknown
-
2022
- 2022-06-20 CL CL2022001712A patent/CL2022001712A1/es unknown
- 2022-06-21 EC ECSENADI202249014A patent/ECSP22049014A/es unknown
Also Published As
Publication number | Publication date |
---|---|
TW202138384A (zh) | 2021-10-16 |
WO2021133907A1 (en) | 2021-07-01 |
CL2022001712A1 (es) | 2023-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2020003255A1 (es) | Proteínas de fusión que comprenden progranulina | |
CO2022008648A2 (es) | Variantes de progranulina | |
CL2022000036A1 (es) | Polipéptidos modificados y usos de los mismos (divisional de solicitud no. 201900261) | |
CY1124309T1 (el) | Τροποποιημενα πολυπεπτιδια fgf-21 και χρησεις εξ αυτων | |
CL2019000325A1 (es) | Composicion farmaceutica que comprende un compuesto derivado de piridona policiclico sustituido o su sal, que tiene actividad inhibidora de la endonucleasa dependiente de cap; cristal; y composicion farmaceutica que comprende dicho cristal. | |
CO2018012096A2 (es) | Proteínas de fusión gdf15 y usos de estas | |
MX2020006322A (es) | Proteinas de fusion il-2 fc modificadas. | |
DOP2019000241A (es) | ANTICUERPOS ANTI-PÉPTIDO BETA AMILOIDE N3pGlu Y SUS USOS | |
SV2018005612A (es) | Agentes, usos y metodos para el tratamiento de la sinucleinopatia | |
CY1122644T1 (el) | Πρωτεϊνες συντηξης tatk-cdkl5, συνθεσεις, φαρμακοτεχνικες μορφες και η χρηση αυτων | |
CR20190480A (es) | Uso de antagonistas de klk5 para el tratamiento de una enfermedad | |
BR112021014944A2 (pt) | Toxinas apxia, apxiia e apxiiia inativas | |
PH12020550927A1 (en) | Therapeutic enzyme fusion protein having novel structure and use thereof | |
SG11202000115SA (en) | Novel therapeutic enzyme fusion protein and use thereof | |
ECSP22049014A (es) | Variantes de progranulina | |
AR115565A1 (es) | Proteínas de fusión que comprenden progranulina | |
ECSP22019177A (es) | Proteínas de fusión nkg2d y sus usos | |
MX2022014899A (es) | Variantes y composiciones del lfa3 y sus usos. | |
EA202190062A1 (ru) | Слитые белки, содержащие програнулин | |
AR114938A1 (es) | Variantes de expresión de cdkl5 y proteínas de fusión cdkl5 | |
AR120892A1 (es) | Variantes de progranulina | |
AR119984A1 (es) | Proteínas de fusión nkg2d y sus usos |